BRPI0513423A - derivados de saliciltiazol substituìdos com difenilamina e compostos relacionados como inibidores de fosfatase de fosfotirosina 1b (ptp1b), para utilização como substáncias ativas redutoras de açúcar no sangue, para tratamento de diabetes - Google Patents
derivados de saliciltiazol substituìdos com difenilamina e compostos relacionados como inibidores de fosfatase de fosfotirosina 1b (ptp1b), para utilização como substáncias ativas redutoras de açúcar no sangue, para tratamento de diabetesInfo
- Publication number
- BRPI0513423A BRPI0513423A BRPI0513423-4A BRPI0513423A BRPI0513423A BR PI0513423 A BRPI0513423 A BR PI0513423A BR PI0513423 A BRPI0513423 A BR PI0513423A BR PI0513423 A BRPI0513423 A BR PI0513423A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- blood sugar
- treatment
- aryl
- diabetes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008280 blood Substances 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 title 2
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 title 1
- -1 salicyl thiazole derivatives Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 101001087394 Homo sapiens Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 abstract 1
- 102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
DERIVADOS DE SALICILTIAZOL SUBSTITUìDOS COM DIFENILAMINA E COMPOSTOS RELACIONADOS COMO INIBIDORES DE FOSFATASE DE FOSFOTIROSINA 1B (PTP1B), PARA UTILIZAçãO COM SUBSTáNCIAS ATIVAS REDUTORAS DE AçúCAR NO SANGUE, PARA TRATAMENTO DE DIABETES. A presente invenção refere-se a compostos que desenvolvem um efeito terapêutico para diminuir o açúcar do sangue. Os compostos são particularmente apropriados para prevenção e tratamento de diabetes mellitus. A invenção refere-se, portanto, a compostos da fórmula (I), na qual significam: R1, R2, R3, R4, R5, independentemente um do outro,H, F,CL,Br,I,OH,CF~ 3~, NO~ 2~ ,CN, OCF~ 3~, O-(C~ 1~-C~ 6~)-alquila, O-(C~ 1~-C~ 4~)-alcóxi-(C~ 1~-C~ 4~)-alquila, S-(C~ 1~-C~ 6~)-alquila, (C~ 1~-C~ 6~)-alquila, (C~ 2~-C~ 6~)-alquenila, (C~ 3~-C~ 8~)-cicloalquila, O-(C~ 3~-C~ 8~)-cicloaquila, (C~ 3~-C~ 8~)-cicloalquia, (C~ 3~-C~ 8~)-cicloalquenila, O-(C~ 3~-C~ 8~)-cicloalquenila, (C~ 2~-C~ 6~)-alquinila, arila, O-aril (C~ 1~-C~ 8~)-alquileno-arila, O-(C~ 1-C~ 8~)-alquileno-arila, S-arila, CO-NH(C~ 1~-C~ 6~)-alquila, N(C~ 1~-C~ 6~)-alquil)2, NH-SO~ 2~-CH3, SO~ 2~-CH~ 3~, COOH, COO-(C~ 1~-C~ 6~)-alquila, CO-N((C~ 1~-C~ 6~)-alquil)~ 2~; R6: H, (C~ 1~-C~ 6~)-alquila; A: uma ligação, -CH~ 2~-, -NH-, -CH~ 2~-O-, -S-, -CH~ 2~-CH~ 2~-, -CH(CH~ 3~)-; B: NH, NH(C~ 1~-C~ 4~)-alquila, NH(CO); D: fenila, heterociclo; bem comoos sais fisiologicamente compatíves dos mesmos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004034697A DE102004034697A1 (de) | 2004-07-17 | 2004-07-17 | Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung |
| PCT/EP2005/007151 WO2006007959A1 (de) | 2004-07-17 | 2005-07-02 | Diphenylaminsubstituierte salicylthiazolderivate und verwandte verbindungen als phosphotyrosinphosphatase 1b (ptp1b) hemmer zur verwendung als blutzuckersenkende wirkstoffe zur behandlung von diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0513423A true BRPI0513423A (pt) | 2008-05-06 |
Family
ID=34971604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0513423-4A BRPI0513423A (pt) | 2004-07-17 | 2005-07-02 | derivados de saliciltiazol substituìdos com difenilamina e compostos relacionados como inibidores de fosfatase de fosfotirosina 1b (ptp1b), para utilização como substáncias ativas redutoras de açúcar no sangue, para tratamento de diabetes |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7741491B2 (pt) |
| EP (1) | EP1771426B1 (pt) |
| JP (1) | JP2008506643A (pt) |
| KR (1) | KR20070043787A (pt) |
| CN (1) | CN100582098C (pt) |
| AR (1) | AR049588A1 (pt) |
| AT (1) | ATE381551T1 (pt) |
| AU (1) | AU2005263418A1 (pt) |
| BR (1) | BRPI0513423A (pt) |
| CA (1) | CA2574162A1 (pt) |
| DE (2) | DE102004034697A1 (pt) |
| DK (1) | DK1771426T3 (pt) |
| ES (1) | ES2296199T3 (pt) |
| IL (1) | IL180570A0 (pt) |
| MX (1) | MXPA06014443A (pt) |
| PE (1) | PE20060554A1 (pt) |
| PT (1) | PT1771426E (pt) |
| TW (1) | TW200616985A (pt) |
| UY (1) | UY29020A1 (pt) |
| WO (1) | WO2006007959A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| KR20120060207A (ko) | 2009-08-26 | 2012-06-11 | 사노피 | 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| AU2019318209B2 (en) | 2018-08-10 | 2025-09-25 | Diapin Therapeutics, Llc | Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586453B2 (en) * | 2000-04-03 | 2003-07-01 | 3-Dimensional Pharmaceuticals, Inc. | Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 |
| US20050065118A1 (en) * | 2001-10-16 | 2005-03-24 | Jing Wang | Organosulfur inhibitors of tyrosine phosphatases |
| AU2002349705A1 (en) * | 2001-12-03 | 2003-06-17 | Japan Tobacco Inc. | Azole compound and medicinal use thereof |
| CN101103977A (zh) * | 2002-06-05 | 2008-01-16 | 株式会社医药分子设计研究所 | 糖尿病治疗药 |
-
2004
- 2004-07-17 DE DE102004034697A patent/DE102004034697A1/de not_active Withdrawn
-
2005
- 2005-07-02 AT AT05756578T patent/ATE381551T1/de not_active IP Right Cessation
- 2005-07-02 EP EP05756578A patent/EP1771426B1/de not_active Expired - Lifetime
- 2005-07-02 DK DK05756578T patent/DK1771426T3/da active
- 2005-07-02 WO PCT/EP2005/007151 patent/WO2006007959A1/de not_active Ceased
- 2005-07-02 PT PT05756578T patent/PT1771426E/pt unknown
- 2005-07-02 BR BRPI0513423-4A patent/BRPI0513423A/pt not_active IP Right Cessation
- 2005-07-02 ES ES05756578T patent/ES2296199T3/es not_active Expired - Lifetime
- 2005-07-02 CA CA002574162A patent/CA2574162A1/en not_active Abandoned
- 2005-07-02 AU AU2005263418A patent/AU2005263418A1/en not_active Abandoned
- 2005-07-02 MX MXPA06014443A patent/MXPA06014443A/es active IP Right Grant
- 2005-07-02 CN CN200580024146A patent/CN100582098C/zh not_active Expired - Fee Related
- 2005-07-02 KR KR1020077001132A patent/KR20070043787A/ko not_active Withdrawn
- 2005-07-02 DE DE502005002310T patent/DE502005002310D1/de not_active Expired - Lifetime
- 2005-07-02 JP JP2007520705A patent/JP2008506643A/ja not_active Abandoned
- 2005-07-11 PE PE2005000803A patent/PE20060554A1/es not_active Application Discontinuation
- 2005-07-14 TW TW094123824A patent/TW200616985A/zh unknown
- 2005-07-14 AR ARP050102922A patent/AR049588A1/es not_active Application Discontinuation
- 2005-07-15 UY UY29020A patent/UY29020A1/es unknown
-
2006
- 2006-12-12 US US11/609,463 patent/US7741491B2/en not_active Expired - Fee Related
-
2007
- 2007-01-04 IL IL180570A patent/IL180570A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY29020A1 (es) | 2006-02-24 |
| EP1771426B1 (de) | 2007-12-19 |
| IL180570A0 (en) | 2007-06-03 |
| DE502005002310D1 (de) | 2008-01-31 |
| CA2574162A1 (en) | 2006-01-26 |
| DE102004034697A1 (de) | 2006-02-09 |
| ATE381551T1 (de) | 2008-01-15 |
| PT1771426E (pt) | 2008-01-31 |
| US7741491B2 (en) | 2010-06-22 |
| CN100582098C (zh) | 2010-01-20 |
| EP1771426A1 (de) | 2007-04-11 |
| DK1771426T3 (da) | 2008-05-05 |
| CN1989116A (zh) | 2007-06-27 |
| MXPA06014443A (es) | 2007-03-21 |
| HK1104534A1 (en) | 2008-01-18 |
| JP2008506643A (ja) | 2008-03-06 |
| KR20070043787A (ko) | 2007-04-25 |
| ES2296199T3 (es) | 2008-04-16 |
| WO2006007959A1 (de) | 2006-01-26 |
| AU2005263418A1 (en) | 2006-01-26 |
| PE20060554A1 (es) | 2006-06-24 |
| TW200616985A (en) | 2006-06-01 |
| US20070191441A1 (en) | 2007-08-16 |
| AR049588A1 (es) | 2006-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0513423A (pt) | derivados de saliciltiazol substituìdos com difenilamina e compostos relacionados como inibidores de fosfatase de fosfotirosina 1b (ptp1b), para utilização como substáncias ativas redutoras de açúcar no sangue, para tratamento de diabetes | |
| NO20085169L (no) | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes | |
| AR042658A1 (es) | Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores de receptores canabinoides | |
| TNSN07471A1 (en) | Novel 2,4 - dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors | |
| PE20080856A1 (es) | Inhibidores de metaloproteasas de matriz | |
| ATE431345T1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| BRPI0415511A (pt) | derivados de n-[fenil (pirrolidina-2-il) metil] benzamida e da n-[(azepan-2-il) fenilmetil] benzamida, preparação dos mesmos e aplicação dos mesmos em terapia | |
| AR041299A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
| AR047085A1 (es) | Derivados de (3-oxo-3,4-dihidro-quinoxalina-2-il-amino)benzamida y compuestos relacionados como inhibidores de glucogeno fosforilasa para el tratamiento de diabetes y obesidad | |
| AR064307A1 (es) | Monofosfatos utiles para el tratamiento de la inflamacion pulmonar y broncoconstriccion, formulaciones aerosolicas que los contienen, y metodo de preparacion. | |
| RU2010128940A (ru) | Производные бензилфенилциклогексана и способы их применения | |
| WO2007120379A3 (en) | Sulfonanilide analogs as selective aromatase modulators | |
| TW200724136A (en) | Pharmaceutical compositions comprising PPAR modulator | |
| EA200970582A1 (ru) | ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5Н-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH | |
| ATE464895T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen | |
| JP2008506643A5 (ja) | 糖尿病の治療用の血糖値低下活性成分として使用するためのホスホチロシン・ホスファターゼ１ｂ(ｐｔｐ１ｂ)阻害剤としてのジフェニルアミン置換サリチルチアゾール誘導体及び関連化合物 | |
| EA200500348A1 (ru) | N-арилпиперидинзамещенные бифенилкарбоксамиды в качестве ингибиторов секреции аполипопротеина b | |
| BRPI0607031A2 (pt) | combinação sinergìstica de compostos ativos fungicidas | |
| HRP20080367T3 (en) | Use of methylene amide derivatives in cardiovascular disorders | |
| DE602006017543D1 (de) | Neue verbindungen | |
| ZA200602077B (en) | Combinations comprising alpha-2-delta ligands and serotonin/noradrenaline re-up-take inhibitors | |
| MY143953A (en) | 2,3,4,5-tetrahydrobenzo [f][1,4] oxazepine-5-carboxylic acid amide derivates as gamma-secretase inhibitors for the treatment of alzheimer's disease | |
| EA200900478A1 (ru) | Жидкая пестицидная композиция, содержащая n-фенилсемикарбазоновые пестицидные соединения | |
| AR072874A1 (es) | Compuestos insecticidas | |
| ATE512950T1 (de) | Neue cyclische verbindung mit 4- pyridylalkylthiogruppe mit darin eingeführtem (un)substituiertem amino |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011. |